Related Experiment Video
Updated: Mar 3, 2026

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway
Kaishu Li1,2,3, Leping Ouyang1, Mingliang He1,2
1Department of Neurosurgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, PR China.
Purpose:
Numerous studies have reported that glioma patients with isocitrate dehydrogenase 1(IDH1) R132H mutation are sensitive to temozolomide treatment. However, the mechanism of IDH1 mutations on the chemosensitivity of glioma remains unclear. In this study, we investigated the role and the potential mechanism of Nrf2 in IDH1 R132H-mediated drug resistance.
Methods:
Wild type IDH1 (R132H-WT) and mutant IDH1 (R132H) plasmids were constructed. Stable U87 cells and U251 cells overexpressing IDH1 were generated. Phenotypic differences between IDH1-WT and IDH1 R132H overexpressing cells were evaluated using MTT, cell colony formation assay, scratch test assay and flow cytometry. Expression of IDH1 and its associated targets, nuclear factor-erythroid 2-related factor 2 (Nrf2), NAD(P)H quinine oxidoreductase 1 (NQO1), multidrug resistant protein 1 (MRP1) and p53 were analyzed.
Results:
The IDH1 R132H overexpressing cells were more sensitive to temozolomide than WT and the control, and Nrf2 was significantly decreased in IDH1 R132H overexpressing cells. We found that knocking down Nrf2 could decrease resistance to temozolomide. The nuclear translocation of Nrf2 in IDH1 R132H overexpressing cells was lower than the WT and the control groups after temozolomide treatment. When compared with WT cells, NQO1 expression was reduced in IDH1 R132H cells, especially after temozolomide treatment. P53 was involved in the resistance mechanism of temozolomide mediated by Nrf2 and NQO1.
Conclusions:
Nrf2 played an important role in IDH1 R132H-mediated drug resistance. The present study provides new insight for glioma chemotherapy with temozolomide.
Insights
The isocitrate dehydrogenase 1 (IDH1) R132H mutation increases glioma sensitivity to temozolomide by decreasing nuclear factor-erythroid 2-related factor 2 (Nrf2) expression, revealing a key mechanism for drug resistance.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Glioma patients with IDH1 R132H mutations often show temozolomide sensitivity.
- The precise mechanism underlying IDH1 mutations' impact on glioma chemosensitivity is not fully understood.
Purpose of the Study:
- To investigate the role of nuclear factor-erythroid 2-related factor 2 (Nrf2) in IDH1 R132H-mediated drug resistance in glioma.
- To elucidate the potential molecular mechanisms involved.
Main Methods:
- Generated stable U87 and U251 cell lines overexpressing wild-type IDH1 (IDH1-WT) and mutant IDH1 (IDH1 R132H).
- Assessed phenotypic differences using MTT assays, colony formation assays, scratch tests, and flow cytometry.
- Analyzed the expression of IDH1, Nrf2, NAD(P)H quinine oxidoreductase 1 (NQO1), multidrug resistant protein 1 (MRP1), and p53.
Main Results:
- IDH1 R132H overexpressing cells demonstrated increased sensitivity to temozolomide compared to IDH1-WT cells.
- Nrf2 expression and nuclear translocation were significantly decreased in IDH1 R132H cells, particularly after temozolomide treatment.
- Knocking down Nrf2 reduced temozolomide resistance, and reduced NQO1 expression was observed in IDH1 R132H cells, with p53 involvement noted.
Conclusions:
- Nrf2 plays a critical role in IDH1 R132H-mediated temozolomide resistance in glioma.
- This study offers novel insights into glioma chemotherapy strategies involving temozolomide.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation

